DOCSLIB.ORG

Opinion on the Organisation of Resilient Health and Social Care Following the COVID-19 Pandemic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Opinion on the Organisation of Resilient Health and Social Care Following the COVID-19 Pandemic THE ORGANISATION OF RESILIENT HEALTH AND SOCIAL CARE FOLLOWING THE COVID-19 PANDEMIC Opinion of the Expert Panel on effective ways of investing in Health (EXPH) Health Further information on the Health and Food Safety Directorate-General is available on the internet at: http://ec.europa.eu/dgs/health_food-safety/index_en.htm Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of the following information. Luxembourg: Publications Office of the European Union, 2020 © European Union, 2020 Reuse is authorised provided the source is acknowledged. The reuse policy of European Commission documents is regulated by Decision 2011/833/EU (OJ L 330, 14.12.2011, p. 39). For any use or reproduction of photos or other material that is not under the EU copyright, permission must be sought directly from the copyright holders. © Photos : https://www.gettyimages.com/, Health and Food Safety Directorate-General Print ISBN 978-92-76-26123-0 doi:10.2875/158132 EW-06-20-027-EN-C PDF ISBN 978-92-76-26122-3 doi:10.2875/005848 EW-06-20-027-EN-N EXPERT PANEL ON EFFECTIVE WAYS OF INVESTING IN HEALTH (EXPH) Opinion on the organisation of resilient health and social care following the COVID-19 pandemic The EXPH adopted this opinion at the 5th plenary on 25 November 2020 after public hearing on 20 October 2020 The organisation of resilient health and social care following the COVID-19 pandemic About the Expert Panel on effective ways of investing in health (EXPH) Sound and timely scientific advice is an essential requirement for the Commission to pursue modern, responsive and sustainable health systems. To this end, the Commission has set up a multidisciplinary and independent Expert Panel that provides advice on effective ways of investing in health (Commission Decision 2012/C 198/06). The core element of the Expert Panel’s mission is to provide the Commission with sound and independent advice in the form of opinions in response to questions (mandates) submitted by the Commission on matters related to health care modernisation, responsiveness and sustainability. The advice does not bind the Commission. The areas of competence of the Expert Panel include, and are not limited to, primary care, hospital care, pharmaceuticals, research and development, prevention and promotion, links with the social protection sector, cross-border issues, system financing, information systems and patient registers, health inequalities, etc. Expert Panel members De Maeseneer Jan (Chair), De Oliveira Martins Pita Barros Pedro, Garcia-Altes Anna (Vice-Chair), Gruson Damien, Kringos-Pereira Martins Dionne, Lehtonen Lasse, Lionis Christos, McKee Martin, Murauskiene Liubove, Nuti Sabina, Rogers Heather-Lynn, Siciliani Luigi, Stahl Dorothea, Wieczorowska-Tobis Katarzyna, Zacharov Sergej, Zaletel Jelka Contact European Commission DG Health & Food Safety Directorate B: Health Systems, medical products and innovation Unit B1 – Performance of national health systems Office: B232 B-1049 Brussels [email protected] The opinions of the Expert Panel present the views of the independent scientists who are members of the Expert Panel. They do not necessarily reflect the views of the European Commission nor its services. The opinions are published by the European Union in their original language only. 2 The organisation of resilient health and social care following the COVID-19 pandemic ACKNOWLEDGMENTS Members of the Drafting Group are acknowledged for their valuable contribution to this opinion. The members of the Drafting Group are: Expert Panel members Professor Jan De Maeseneer Chair Dr Dionne Kringos Rapporteur Professor Christos Lionis Rapporteur Dr Heather-Lynn Rogers Rapporteur Dr Anna Garcia-Altes Professor Damien Gruson Professor Lasse Lehtonen Professor Martin McKee Dr Liubove Murauskiene Professor Sabina Nuti Professor Pedro Pita Barros Professor Luigi Siciliani Dr Dorothea Stahl Professor Katarzyna Wieczorowska-Tobis Dr Sergej Zacharov Dr Jelka Zaletel The declarations of the Drafting Group members are available at: https://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&gro upID=2847 3 The organisation of resilient health and social care following the COVID-19 pandemic ABSTRACT The COVID-19 pandemic has raised questions about the resilience of health systems across the globe. Many analyses of its impact and the responses adopted have already been published. The Panel received a mandate to look beyond the current crisis and consider how health systems can prepare better for future threats. Specifically, the mandate requested a new framework for the organisation of health and social care following the COVID-19 pandemic. This Opinion (1) identifies the building blocks of resilient health and social care systems, (2) explores the elements and conditions for capacity building to strengthen health system resilience, (3) addresses healthcare provision for vulnerable patient groups and how to sustain such provision in a system under stress, and (4) sets out an approach to develop and implement “resilience tests” of Member State’s health systems. The recommendations target a number of key areas, including: enhancing workforce training and resilience, reviewing research and development and procurement (especially for innovative medicines), identifying and reducing disinformation, fostering inter- professional and inter-sectoral collaboration with community health workers and informal care givers for example, integrating information and communication technologies across care levels and public health, strengthening primary and mental health care, increasing public health focus on psychological distress, debating methods for Member States to collect and share aggregate health data on ethnicity and socioeconomic status, developing and deploying online trainings for frontline health and social care professionals regarding care provision to vulnerable groups, and finally investing from the European Commission in the development and implementation of (a) comprehensive resilience testing of health systems that use qualitative and quantitative data collection methodologies to generate meaningful, actionable results for health system transformation, and (b) corresponding learning communities within and across Member States to share lessons learned through this process. Keywords: care organisation, health care, social care, building blocks, capacity building, vulnerable groups, health systems resilience, resilience-testing, ‘SARS-CoV-2’, COVID-19 Opinion to be cited as: Expert Panel on effective ways of investing in health (EXPH), The organisation of resilient health and social care following the COVID-19 pandemic, 25 November 2020 © European Union, 2020 ISSN 2315-1404 ISBN doi:xxxx ND-xxx https://ec.europa.eu/health/exph/overview_en 4 The organisation of resilient health and social care following the COVID-19 pandemic TABLE OF CONTENTS ACKNOWLEDGMENTS ...................................................................................................................................... 3 ABSTRACT ........................................................................................................................................................ 4 EXECUTIVE SUMMARY ..................................................................................................................................... 7 BACKGROUND .................................................................................................................................................. 9 THE RESILIENCE OF HEALTH SYSTEMS IN THE SPOTLIGHT .................................................................................................. 10 QUESTIONS FOR THE EXPERT PANEL .............................................................................................................. 13 1. OPINION ................................................................................................................................................. 15 1.1. COVID-19 AND THE RESILIENCE OF HEALTH SYSTEMS ........................................................................................ 15 1.1.1. Building blocks to improve the care organisation ......................................................................... 15 1.1.2. A multidimensional conceptual framework .................................................................................. 18 1.1.3. Assessing the resilience of health systems .................................................................................... 19 1.1.4. European initiatives on resilience of health systems ..................................................................... 20 1.2. CONDITIONS FOR CAPACITY BUILDING OF RESILIENT HEALTH AND SOCIAL CARE ........................................................ 22 1.2.1. Responding to unintended consequences ..................................................................................... 22 1.2.2. Integrating and using different forms of information for actionable decision-making ................. 24 1.2.3. Disseminating knowledge and good practice ................................................................................ 29 1.2.4. Anticipating and coping with uncertainties and unplanned events .............................................. 31 1.2.5. Managing interdependence and cooperation of different actors ................................................. 34 1.2.6. Building or developing legitimate institutions, measures and norms
Load more

Recommended publications
  • (MGH) COVID-19 Treatment Guidance
    Version 8.0 4/28/2021 10:00AM © Copyright 2020 The General Hospital Corporation. All Rights Reserved. Massachusetts General Hospital (MGH) COVID-19 Treatment Guidance This document was prepared (in March, 2020-April, 2021) by and for MGH medical professionals (a.k.a. clinicians, care givers) and is being made available publicly for informational purposes only, in the context of a public health emergency related to COVID-19 (a.k.a. the coronavirus) and in connection with the state of emergency declared by the Governor of the Commonwealth of Massachusetts and the President of the United States. It is neither an attempt to substitute for the practice of medicine nor as a substitute for the provision of any medical professional services. Furthermore, the content is not meant to be complete, exhaustive, or a substitute for medical professional advice, diagnosis, or treatment. The information herein should be adapted to each specific patient based on the treating medical professional’s independent professional judgment and consideration of the patient’s needs, the resources available at the location from where the medical professional services are being provided (e.g., healthcare institution, ambulatory clinic, physician’s office, etc.), and any other unique circumstances. This information should not be used to replace, substitute for, or overrule a qualified medical professional’s judgment. This website may contain third party materials and/or links to third party materials and third party websites for your information and convenience. Partners is not responsible for the availability, accuracy, or content of any of those third party materials or websites nor does it endorse them.
    [Show full text]
  • Can Communication Strategies Combat COVID-19 Vaccine
    Article Can Communication Strategies Combat COVID-19 Vaccine Hesitancy with Trade-Off between Public Service Messages and Public Skepticism? Experimental Evidence from Pakistan Qiang Jin 1, Syed Hassan Raza 2 , Muhammad Yousaf 3 , Umer Zaman 4,* and Jenny Marisa Lim Dao Siang 5 1 Intercultural Communication Research Center, Hebei University, Baoding 071000, China; [email protected] 2 Department of Communication Studies, Bahauddin Zakariya University, Multan 66000, Pakistan; [email protected] 3 Centre for Media and Communication Studies, University of Gujrat, Gujrat 50700, Pakistan; [email protected] 4 Endicott College of International Studies, Woosong University, Daejeon 34606, Korea 5 Department of Business Administration, School of Management, National Central University, Taoyuan City 32001, Taiwan; [email protected] * Correspondence: [email protected] Abstract: The COVID-19 pandemic may have reached a turning point as the World Health Organiza- tion and the global community of nations step up plans for mass vaccination campaigns. However, the COVID-19 vaccine-related conspiracy theories (e.g., falsehoods about birth control, women infer- tility, surveillance, and microchip humanity, etc.) have built new momentum for vaccine hesitancy. To this end, several nations worldwide, including Pakistan, are struggling to boost public trust Citation: Jin, Q.; Raza, S.H.; Yousaf, and enthusiasm to get vaccinated, especially in an anxious and complicated atmosphere propelled M.; Zaman, U.; Siang, J.M.L.D. Can by multiple, new
    [Show full text]
  • Progress in the Development of Potential Therapeutics and Vaccines Against COVID-19 Pandemic
    Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423) Volume 5 Issue 7 July 2021 Review Article Progress in the Development of Potential Therapeutics and Vaccines against COVID-19 Pandemic Abhishek Kumar Yadav, Shubham Kumar and Vikramdeep Monga* Received: May 02, 2021 Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, Published: June 09, 2021 India © All rights are reserved by Vikramdeep *Corresponding Author: Vikramdeep Monga, Department of Pharmaceutical Monga., et al. Chemistry, ISF College of Pharmacy, Moga, Punjab, India. Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 or coronavirus disease 2019 and the same has been declared as a global pandemic by WHO which marked the third introduction of a virulent coronavirus into human society. This a threat to human life worldwide. Considerable efforts have been made for developing effective and safe drugs and vaccines against is a highly pathogenic human coronavirus in which pneumonia of unknown origin was identified in China in December 2019 and is SARS-CoV-2. The current situation and progress in the development of various therapeutic candidates including vaccines in preclini- cal and clinical studies have been described in the manuscript. Until now, many people have been infected with this lethal virus, and a lot of people have died from this COVID-19. This viral disease spreads by coming in contact with an infected person. Understand- ing of SARS-CoV-2 is growing in relation to its epidemiology, virology, and clinical management strategies. Till date, very few drugs or vaccines have been developed or approved for the treatment of this deadly disease of COVID-19 and many candidates are under the clinical development pipeline.
    [Show full text]
  • Impact of SARS-Cov-2 Variant on the Severity of Maternal Infection and Perinatal Outcomes: Data from the UK Obstetric Surveillan
    medRxiv preprint doi: https://doi.org/10.1101/2021.07.22.21261000; this version posted July 25, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: Data from the UK Obstetric Surveillance System national cohort. Nicola Vousden PhD1, Rema Ramakrishnan PhD1, Kathryn Bunch MA1, Edward Morris MD2, Nigel Simpson MBBS3, Christopher Gale PhD4, Patrick O’Brien MBBCh,2,5, Maria Quigley MSc1, Peter Brocklehurst MSc6, Jennifer J Kurinczuk MD1, Marian Knight DPhil1 1National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK 2Royal College of Obstetricians and Gynaecologists, London, UK 3Department of Women's and Children's Health, School of Medicine, University of Leeds, UK 4Neonatal Medicine, School of Public Health, Faculty of Medicine, Imperial College London, London, UK 5Institute for Women’s Health, University College London, London, UK 6Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, UK *Corresponding author: Marian Knight National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK 01865 289700 [email protected] NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 1 medRxiv preprint doi: https://doi.org/10.1101/2021.07.22.21261000; this version posted July 25, 2021.
    [Show full text]
  • Do You Know of a Colleague And/Or Student Who Would Be Interested in Receiving These Bulletin Boards? Please Forward to Them
    Do you know of a colleague and/or student who would be interested in receiving these Bulletin Boards? Please forward to them. A quick email to [email protected] with the word “subscribe” in the subject line and the email address will be added to the listing. Geoscience Bulletin Board – 16 November 2020 – compiled by Elaine J. Hanford In Memoriam: Will Harrison (1936- 2020) – raffish glacial scientist • https://www.adn.com/alaska-news/science/2020/11/07/saying-goodbye-to-a-raffish-glacier- scientist/ Understanding Jökulhlaup - glacial lake floods • https://www.techexplorist.com/long-standing-mystery-glacial-lake-floods-solved/36039/ Distinct slab interfaces within mantle transition zone beneath western Pacific • https://www.eurekalert.org/pub_releases/2020-11/caos-dsi110920.php New model for predicting speed of earthquake propagation • https://www.eurekalert.org/pub_releases/2020-11/idrp-anm110920.php Dust in sediment cores from South Pacific reflect Ice Age climate history • https://www.eurekalert.org/pub_releases/2020-11/uoo-had110920.php Dotsero volcano in Colorado erupted roughly 4,200 years ago – phreatomagmatic eruption • https://coloradosun.com/2020/11/09/dotsero-volcano-colorado-active/ San Cristobal Verapaz deadly landslide triggered by heavy rains from Hurricane Eta in Guatemala • https://blogs.agu.org/landslideblog/2020/11/09/san-cristobal-verapaz/ Somalia heralding new oil & gas exploration • https://www.theafricareport.com/49364/somalia-the-new-oil-and-gas-frontier/ Drones measuring carbon dioxide emissions from Manam
    [Show full text]
  • An Examination of COVID-19 Medications' Effectiveness
    healthcare Review An Examination of COVID-19 Medications’ Effectiveness in Managing and Treating COVID-19 Patients: A Comparative Review Mahmoud Al-Masaeed 1,* , Mohammad Alghawanmeh 2, Ashraf Al-Singlawi 3 , Rawan Alsababha 4 and Muhammad Alqudah 1 1 Faculty of Health and Medicine, University of Newcastle, Callaghan 2308, Australia; [email protected] 2 Faculty of Pharmacy, Philadelphia University, Amman 19392, Jordan; [email protected] 3 Independent Scholar, Amman 11731, Jordan; [email protected] 4 School of nursing and Midwifery, Western Sydney University, Sydney 2560, Australia; [email protected] * Correspondence: [email protected] Abstract: Background: The review seeks to shed light on the administered and recommended COVID- 19 treatment medications through an evaluation of their efficacy. Methods: Data were collected from key databases, including Scopus, Medline, Google Scholar, and CINAHL. Other platforms included WHO and FDA publications. The review’s literature search was guided by the WHO Citation: Al-Masaeed, M.; solidarity clinical trials for COVID-19 scope and trial-assessment parameters. Results: The findings Alghawanmeh, M.; Al-Singlawi, A.; indicate that the use of antiretroviral drugs as an early treatment for COVID-19 patients has been Alsababha, R.; Alqudah, M. An useful. It has reduced hospital time, hastened the clinical cure period, delayed and reduced the Examination of COVID-19 need for mechanical and invasive ventilation, and reduced mortality rates. The use of vitamins, Medications’ Effectiveness in minerals, and supplements has been linked to increased immunity and thus offering the body a Managing and Treating COVID-19 fighting chance. Nevertheless, antibiotics do not correlate with improving patients’ wellbeing and Patients: A Comparative Review.
    [Show full text]
  • Coronaconspiracy: Conspiracy Theories on Twitter and Youtube in the Age of Coronavirus Author: Sam Dodd // Institution: City, U
    #Coronaconspiracy: Conspiracy Theories on Twitter and YouTube in the Age of Coronavirus Author: Sam Dodd // Institution: City, University of London // Academic Year: 2019-2020 “When you have a situation where something defies explanation, people want better explanations than they’re getting, and that’s where conspiracy theories come from, that’s where they’ve always come from. People need to bring order to chaos” (VICE, 2020, 4:35). This essay will examine the most popular conspiracy theories circulated on Twitter and YouTube about the 2019-20 global pandemic COVID-19 (coronavirus), in the English language, for the one-week time frame 5th May 2020 – 11th May 2020, then examine news coverage originating from UK-based outlets related to those conspiracy theories for the two month period preceding this time frame, for background and context. It will ask what the roles of the law and regulators, the platforms themselves, and the information professional could be in this context. ~ Terminology The way that ‘most popular’ is measured is explained in ‘Twitter and YouTube Data Analysis: Research Parameters’ further on. The term ‘conspiracy theory’ is defined as: “the theory that an event or phenomenon occurs as a result of a conspiracy between interested parties; a belief that some covert but influential agency (typically political in motivation and oppressive in intent) is responsible for an unexplained event” (Oxford English Dictionary, 2020). This essay will explore what interested parties or influential agencies conspiracy theorists claim exist; and the motivation or intent that these agencies allegedly have. Background ‘COVID-19’, known also as ‘SARS-CoV-2’ and ‘Coronavirus Disease’, is a respiratory tract virus first identified in December 2019 in Hubei, a province of China.
    [Show full text]
  • AN ETHICO-EPISTEMIC PERSPECTIVE on COVID-19 Jude I. Onebunne* Abstract the Chequered History of Humanity Is Reckoned with Diseas
    AN ETHICO-EPISTEMIC PERSPECTIVE ON COVID-19 Jude I. Onebunne* Abstract The chequered history of humanity is reckoned with diseases and has recorded outbreaks of dangerous and contagious diseases often referred to as plagues otherwise pandemics. These disease outbreaks ravage humanity interfering greatly in the course of history and at times, signaling the end of an entire civilization in other to reintroduce a complete new world order. At the dawn of Anno Domino 2020, amidst great expectations of pomp and pageantries of a promising new year, we woke up to the confusing news of COVID-19, the brouhaha of the novel Coronavirus disease. Like a joke amidst inherent confusion on its nature, structure and curative status, COVID-19 started spreading geometrically and like a wild fire with corresponding death tolls. This paper tries to critically view and review the whole episode surrounding COVID-19 Pandemic while at the same time appreciates the role of philosophy in the proper and effective handling of COVID- 19 that has come to stay like other pestilences of the past. Keywords: Philosophy, Ethics, Epistemic, COVID-19, Epidemic, Pandemic Introduction Humanity has over the time experienced deadly and brutal outbreak of virulent diseases. They were simply vicious and vile killers in human history. Epidemics, endemics, plagues and pandemics are all part and parcel of human existence that has to do with ill state or poor health of man. Most often, what may be regarded as worrisome as epidemic turns out to be mere sickness in other parts of the world like the dreaded Malaria and scary typhoid fever.
    [Show full text]
  • Official Report of This Meeting
    COVID-19 Committee Thursday 18 February 2021 Session 5 © Parliamentary copyright. Scottish Parliamentary Corporate Body Information on the Scottish Parliament’s copyright policy can be found on the website - www.parliament.scot or by contacting Public Information on 0131 348 5000 Thursday 18 February 2021 CONTENTS Col. CITIZENS PANEL ................................................................................................................................................ 5 SUBORDINATE LEGISLATION............................................................................................................................. 26 Personal Protective Equipment (Temporary Arrangements) (Coronavirus) (Scotland) Regulations 2021 (SSI 2021/50) ............................................................................................................. 26 Health Protection (Coronavirus) (Restrictions and Requirements) (Local Levels) (Scotland) Amendment (No 16) Regulations 2021 [Draft] ........................................................................................ 26 COVID-19 COMMITTEE 6th Meeting 2021, Session 5 CONVENER *Donald Cameron (Highlands and Islands) (Con) DEPUTY CONVENER Monica Lennon (Central Scotland) (Lab) COMMITTEE MEMBERS *Willie Coffey (Kilmarnock and Irvine Valley) (SNP) *Maurice Corry (West Scotland) (Con) *Annabelle Ewing (Cowdenbeath) (SNP) *John Mason (Glasgow Shettleston) (SNP) *Stuart McMillan (Greenock and Inverclyde) (SNP) *Mark Ruskell (Mid Scotland and Fife) (Green) *Beatrice Wishart (Shetland Islands) (LD)
    [Show full text]
  • Covid-19, Free Speech, Hate Speech: Implications for Journalism Teaching
    COVID-19, FREE SPEECH, NEWS REPORTING 1 Running head: COVID-19, FREE SPEECH, NEWS REPORTING Covid-19, Free Speech, Hate Speech: Implications for Journalism Teaching Jerry Crawford1, Anastasia Kononova2, Mia Moody-Ramirez3 and Carolyn Bronstein4 Abstract The essay stems from conversations and research from AEJMC’s “Recommended EthicaL ProfessionaL Freedom & ResponsibiLity GuideLines.” It is from this perspective that we address the handling of free speech during the Covid-19 pandemic and how threats to free speech, particularly during raciaLLy charged periods, may affect teaching in journaLism and mass communication programs. Further, we discuss instances in which free speech is used during a crisis to contribute to raciaL and ethnic stereotypes and exacerbate sociopoliticaL divisions. We incLude background and context on the pandemic and how the media covered it; implications of misinformation and free speech; sourcing and citizen journaLism; and various types of hate speech. 1 Associate Professor at William Allen White School of Journalism and Mass Communication, The University of Kansas 2 Assistant Professor in the Department of Advertising + Public Relations, Michigan State University 3 Professor in the Department of Journalism, PuBlic Relations & New Media, Baylor University 4 Professor of Media Studies in the College of Communication, DePaul University COVID-19, FREE SPEECH, NEWS REPORTING 2 The year into the current Covid-19 pandemic has brought irreversible changes to the globaL community. This pandemic presents an important opportunity for journaLism and communication educators to consider the interplay among misinformation, free speech, hate speech and cLassroom teaching – whether in-person or virtuaL. The pandemic is not only a heaLth concern, but it is aLso a politicaLLy divisive topic that has been debated from various perspectives.
    [Show full text]
  • Pandemic Planning , File Type: PDF, File Size
    July 2021 Dear ATISN 15194 – Pandemic Planning Thank you for your request to the Welsh Government for information under the Freedom of Information Act (2000) received on 03 June 2021. I have interpreted your requested information regarding pandemic planning as follows: 1. What plans were in place for a potential future pandemic before the COVID19 crisis began? 2. What conversations were had at ministerial level, before COVID19, about the potential of a future pandemic? 3. What plans are now in place for a future pandemic, if any? Our Response What plans were in place for a potential future pandemic before the COVID-19 crisis began? Wales, together with the rest of the UK, has been preparing its response to an influenza pandemic for many years. In 2007, Wales participated in the UK level (Tier 1) pandemic flu exercise Winter Willow, which led to the development of the 2007 National Framework for Responding to an Influenza Pandemic. This framework was used to support our Welsh Government response to the 2009 H1N1 Swine Flu pandemic. Although the H1N1 pandemic was not as severe as initially predicted, it did identify areas for further planning and Wales worked with the other UK governments to put in place the UK Influenza Preparedness Strategy 2011. This UK Strategy was agreed by the Health Ministers of all four nations. In 2016, our pandemic influenza plans were tested during Exercise Cygnus. The subsequent lessons identified were taken forward into an ongoing review of pandemic preparedness led by the UK Cabinet Office and Department of Health and Social Care.
    [Show full text]
  • COVID-Clinical-Update.Pdf
    COVID-19 Update Jorge Mera, MD Whitney Essex, APRN Questions • I have heard that the only thing that will end this pandemic is acquisition of immunity. That means either natural or by vaccination, therefore, in the absence of vaccination, we should be encouraging natural immunity (infection with recovery) rather than advocating avoidance. Any chosen path will result in casualties. however, our current path of avoidance is drawing out the process and hurting our nation. Please comment. • Prescriptions for zithromax and hydroxychloroquine have skyrocketed across the nation. Is there any role for these medications for outpatients, either prophylactically or for treatment? Please also discuss other treatments being advocated such as zinc. Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries • Non-pharmacological interventions (NPI) have been the mainstay for controlling the COVID-19 pandemic. • While NPIs are effective in preventing health systems overload, these long-term measures are likely to have significant adverse economic consequences • Many countries are currently considering to lift the NPIs • Dynamic NPIs, with intervals of relaxed social distancing, may provide a more suitable alternative, • But the ideal frequency and duration of intermittent NPIs, and the ideal “break” when interventions can be temporarily relaxed, remain uncertain • Multivariate prediction model, based on up-to-date transmission and clinical parameters, to simulate outbreak traJectories in 16 countries, from diverse regions and economic categories. • In each country, we then modelled the impacts on intensive care unit (ICU) admissions and deaths over an 18-month period for following scenarios: 1. No intervention 2. Consecutive cycles of mitigation measures followed by a relaxation period 3.
    [Show full text]